EDGAR Filing Documents for 0001193125-22-181591

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-22-181591

Filing Date

2022-06-24

Accepted

2022-06-24 16:43:30

Documents

Effectiveness Date

2022-06-24

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d283968ds8.htm	S-8	57167
2	EX-5.1	d283968dex51.htm	EX-5.1	10835
3	EX-23.1	d283968dex231.htm	EX-23.1	1470
4	EX-99.2	d283968dex992.htm	EX-99.2	55408
5	EX-99.3	d283968dex993.htm	EX-99.3	33411
6	EX-99.5	d283968dex995.htm	EX-99.5	62869
7	EX-99.6	d283968dex996.htm	EX-99.6	33506
8	EX-99.7	d283968dex997.htm	EX-99.7	94223
9	EX-99.8	d283968dex998.htm	EX-99.8	59744
10	EX-99.9	d283968dex999.htm	EX-99.9	33067
11	EX-99.10	d283968dex9910.htm	EX-99.10	74315
12	EX107	d283968dexfilingfees.htm	EX-FILING FEES	50559
13	GRAPHIC	g283968snap0020.jpg	GRAPHIC	6484
14	GRAPHIC	g283968snap0021.jpg	GRAPHIC	3287
	Complete submission text file	0001193125-22-181591.txt		581476

Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709

Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835

G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)